Riken Vitamin Co., Ltd. (4526.T) JPX

2,995.00

+45(+1.53%)

Updated at December 25 12:45PM

Currency In JPY

Valuation

Market Cap73.24B
Enterprise Value60.86B
P/E Ratio9.34
PEG Ratio1.21
Price/Sales Ratio0.93
Price/Book Ratio1.1
Enterprise/Revenue0.84
Enterprise/EBITDA5.11

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.1
Operating Margin0.09

Management Effectiveness

Return On Assets0.08
Return On Equity0.12

Income Statement

Revenue95.58B
Revenue/Share3,231.13
Gross Profit31.27B
EBITDA16.04B
Net Income9.39B
Diluted EPS310.06

Balance Sheet

Total Cash17.32B
Total Cash/Share584.76
Total Debt8.66B
Total Debt/Equity0.11
Current Ratio3.15
Book Value Per Share2,723.76

Price History

52-Week Change23.51
52-Week High3,025
52-Week Low2,204
Moving Average 50 Days2,867.68
Moving Average 200 Days2,731.7

Statistics

Average Volume73,270
Shares Outstanding29.57M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate108.5
Trailing Annual Dividend Yield3.62
Payout Ratio0
Last Split Factor2:1
Last Split DateMarch 30, 2020